

Aptensio XR is an extended-release methylphenidate capsule for ADHD. Learn about its uses, dosage strengths, how to take it, cost, and more.
Aptensio XR is a brand-name, extended-release capsule containing Methylphenidate Hydrochloride, a central nervous system (CNS) stimulant used to treat Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older.
It is manufactured by Rhodes Pharmaceuticals L.P. (a subsidiary of Purdue Pharma) and was approved by the FDA for the treatment of ADHD. Aptensio XR is classified as a Schedule II controlled substance due to its potential for abuse and dependence.
Aptensio XR is FDA-approved for one indication:
ADHD is a neurodevelopmental condition characterized by persistent patterns of inattention, hyperactivity, and impulsivity that interfere with daily functioning. Aptensio XR helps manage these symptoms by increasing the availability of dopamine and norepinephrine in the brain.
Some doctors may also prescribe Methylphenidate off-label for conditions like narcolepsy or treatment-resistant depression, though Aptensio XR specifically is primarily used for ADHD.
For a deeper explanation of how it works, see our article on Aptensio XR's mechanism of action.
Aptensio XR is taken once daily in the morning, with or without food. Here are the key details:
Aptensio XR uses multilayer bead technology to deliver an initial dose quickly, followed by a gradual release over the rest of the day. Most patients experience symptom relief for approximately 10-12 hours.
Aptensio XR is not appropriate for everyone. You should not take it if you have:
Use with caution if you have:
Your doctor will evaluate your medical history before prescribing. For a complete list of potential interactions, see our drug interactions guide.
Like all stimulant medications, Aptensio XR has potential side effects. The most common include:
Serious side effects are less common but include cardiovascular events (increased heart rate and blood pressure), psychiatric symptoms (hallucinations, mania), and peripheral vasculopathy. Aptensio XR also carries an FDA boxed warning about its potential for abuse and dependence.
For a detailed breakdown, read our full guide on Aptensio XR side effects.
Cost depends on whether you're filling brand-name or generic, and whether you have insurance:
Insurance coverage varies widely. Many plans prefer generic methylphenidate formulations or Concerta, and may require prior authorization or step therapy before covering brand-name Aptensio XR.
Ways to save:
For a comprehensive look at all savings options, see our guide to saving money on Aptensio XR.
Yes. Generic methylphenidate extended-release capsules are available and are typically much cheaper than brand-name Aptensio XR. However, different generic formulations may use different release mechanisms, so switching between brands may affect how the medication works for you. Talk to your doctor if you notice any changes after switching.
Aptensio XR is one of several extended-release methylphenidate formulations on the market. Here's how it compares:
The best medication depends on your individual response, side effect profile, and insurance coverage. For more options, see our alternatives to Aptensio XR.
Aptensio XR is a well-established, once-daily ADHD medication with a flexible dosing range and the convenience of being sprinkled on food if you can't swallow capsules. Whether you're newly diagnosed or considering a switch from another medication, understanding how it works, what it costs, and what to expect can help you make an informed decision with your doctor.
If you need help finding Aptensio XR at a pharmacy near you, Medfinder can show you which pharmacies have it in stock right now.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.